Cargando…
Cold Atmospheric Plasma: A New Strategy Based Primarily on Oxidative Stress for Osteosarcoma Therapy
Osteosarcoma is the most common primary bone tumor, and its first line of treatment presents a high failure rate. The 5-year survival for children and teenagers with osteosarcoma is 70% (if diagnosed before it has metastasized) or 20% (if spread at the time of diagnosis), stressing the need for nove...
Autores principales: | Mateu-Sanz, Miguel, Tornín, Juan, Ginebra, Maria-Pau, Canal, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926371/ https://www.ncbi.nlm.nih.gov/pubmed/33672274 http://dx.doi.org/10.3390/jcm10040893 |
Ejemplares similares
-
Cold Plasma-Treated Ringer’s Saline: A Weapon to Target Osteosarcoma
por: Mateu-Sanz, Miguel, et al.
Publicado: (2020) -
Pyruvate Plays a Main Role in the Antitumoral Selectivity of Cold Atmospheric Plasma in Osteosarcoma
por: Tornin, Juan, et al.
Publicado: (2019) -
Osteosarcoma tissue-engineered model challenges oxidative stress therapy revealing promoted cancer stem cell properties
por: Tornín, Juan, et al.
Publicado: (2021) -
Production of reactive species in alginate hydrogels for cold atmospheric plasma-based therapies
por: Labay, Cédric, et al.
Publicado: (2019) -
Cold Atmospheric Plasma in the Treatment of Osteosarcoma
por: Gümbel, Denis, et al.
Publicado: (2017)